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symptoms continued after dilatation; 13 others had
occasional symptoms only. Though health gradually
deteriorates even if symptoms are controlled by
dilatation and drugs, 41 patients had a satisfactory
quality of life after surgery (groups SA, B, and C)
There was no appreciable difference in either post-
operative mortality or recurrence of symptoms in the
two groups having conservative or radical surgery. The
30 day mortality was similar to that reported for
younger patients" and might be reduced with better
selection of patients. The five year survival in our
patients was 68%. More elderly patients should be
considered for surgery for oesophageal stricture.
1 Stoddard CJ, Simms JM. Dilatation of benign oesophageal strictures in the
outpatient department. BrJ Surg 1984;71:752-3.
2 Croker JR, Vallon AG, Cotton PB. Benign oesophageal stricture in the elderly-
use of cimetidine and fibre-optic dilatation. Age Ageing 1980;9:53-8.
3 Williamson RCN. The management of peptic oesophageal stricture. BrJ Surg
1975;62:448-54.
4 Fanshal S, Bush JW. A health-status index and its application to health-services
outcomes. Operations Research 1970;18:1021-66.
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There is strong epidemiological evidence to support a
relation between colonisation of the gastric antrum
with Helicobacter pylon' (previously Campylobacter
pylon) and duodenal ulcers,' though the basis of this
association is speculative. We recently showed that in
patients with duodenal ulcers secretion of gastric acid
stimulated by pentagastrin and postprandial plasma
gastrin concentrations are significantly higher in
patients positive forH pylon' than in those negative for
the organism.2 In the present study we examined
whether the high postprandial gastrin concentrations
respond to treatment that eradicates H pylon'.
Patients, methods, and results
We studied 51 patients with active duodenal ulcers.
Seven were negative for H pylon' and 44 positive on
urease testing of antral biopsy specimens.2 Secretion
of gastric acid was determined with pentagastrin
(6 [g/kg/h). Venous blood was collected before and
after a standard meal for radioimmunoassay of gastrin.2
Peak secretion of acid stimulated by pentagastrin
was 45 2 (SEM 3 0) mmol/h in the patients who were
positive for H pylon compared with 29-7 (4 0) mmol/h
in those who were negative (p<0 05). Basal gastrin
concentrations were significantly higher in the
patients who were positive for H pylori (13 1 (2 0)
v 6-3 (2-6) pmol/l, p<005). Integrated plasma
gastrin responses to the standard meal were 1564
(267) pmol.min/l in the patients positive for H pylon'
and 965 (248) pmol.min/l in those negative forH pylorn
(p<O0O5).
Ten of the patients positive forH pylon were treated
with metronidazole 400 mg thrice daily for two weeks
and colloidal bismuth subcitrate 120 mg four times
daily for four weeks.- Two days after completing
treatment nine patients were negative for the organism.
Integrated postprandial gastrin responses fell from
1184 (350) to 498 (117) pmol.min/l (p=0005) while
peak rates of secretion of acid remained unchanged
(figure). Basal gastrin concentrations, however, were
not significantly lower after treatment (7-5 (1 8) v 6-7
(1 -9) pmol/l, respectively).
Comment
We showed that eradicating antral H pylon' in
patients with duodenal ulcers leads to a significant
drop in the postprandial response of plasma gastrin
concentration. This supports our contention that
H pylon is responsible for hypergastrinaemia in
patients with duodenal ulcers.2
Patients with duodenal ulcer disease tend to have
higher rates of secretion of gastric acid and higher
postprandial plasma gastrin concentrations than,
controls. Walsh et al showed that a low intragastric pH
inhibits release of gastrin less effectively in patients
with duodenal ulcer disease than in normal subjects.4
On the basis of our recent results2 we proposed that
H pylori in the gastric antrum increases the release of
gastrin. H pylon produces a powerful urease that splits
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urea in the stomach to produce ammonia. We therefore
postulate that ammonia increases the pH in the mucus
layer that overlies the gastric antrum, resulting in
impairment of the normal inhibition of gastrin release
by intraluminal acid.
This is the first report of a fall in postprandial plasma
gastrin responses after eradication of H pylon in
patients with duodenal ulcers. This could explain the
reduced likelihood of relapse of ulcers in patients
treated with agents that suppress or eradicateH pylon'. '
The fall in postprandial plasma gastrin concentrations,
which does not occur after treatment with H2 ant-
agonistss and is therefore not simply a result of the
ulcer healing, would be expected to result in a
diminished postprandial secretory drive on the gastric
parietal cells. Another probable long term result of the
lower gastrin concentrations is a reduction in the
number of parietal cells owing to a reduction in the
trophic effect of gastrin on these cells. Peak acid
output, which reflects the parietal cell mass, did not
fall significantly in our patients after one month of
treatment to eradicate H pylon' despite the lower
gastrin concentrations. Thus a longer period of
treatment may be needed before the number of parietal
cells falls.
We thank SisterM L Francis Reme and her endoscopy staff
for their hard work and Mr John Spencer for allowing us to
study his patients. SL was supported by the British Digestive
Foundation, KB by the Wellcome Trust, and RP by the
Medical Research Council.
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Patients with subacute thyroiditis classically present
with fever, neck pain, and a tender goitre. Functional
changes in thyroid state include both hyperthyroidism
and hypothyroidism. Constitutional symptoms may,
however, be absent and patients may present with
features of hyperthyroidism alone, thus making
differentiation from other causes of hyperthyroidism
difficult. Nevertheless, differentiation is important as
the implications for treatment are different. In such
cases measurement of the uptake of radioiodine by the
thyroid gland is useful, but it may not be measured
unless thyroiditis is suspected. Thus the disorder may
be misdiagnosed and patients given inappropriate
treatment.
As patients with subacute thyroiditis are hyper-
thyroid for a short time a marker that reflects the
duration of their hyperthyroidism might be useful in
differentiating their condition from established
hyperthyroidism-for example, that due to Graves'
disease. Erythrocyte zinc concentrations are decreased
in patients with established hyperthyroidism.' Because,
however, the circulating life span' of erythrocytes is
long, the erythrocyte zinc concentration reflects the
integrated functional state of the thyroid over a period
of months. Thus the erythrocyte zinc concentration
may be used to differentiate between transient
hyperthyroidism and established hyperthyroidism
lasting more than two to three months. We previously
reported that the erythrocyte zinc concentration
differentiated between transient hyperthyroxinaemia
associated with hyperemesis gravidarum and pre-
existing thyrotoxicosis,2 and we report the results in
patients with transient hyperthyroidism associated
with subacute thyroiditis.
Patients, methods, and results
We studied five patients (four women and one man
ranging in age from 35 to 42) with clinically incontro-
vertible subacute thyroiditis. Hyperthyroidism was
suspected clinically in four of them and was confirmed
in all five by measuring the concentrations of thyroid
hormones. All five patients presented with fever,
anterior neck pain, a tender goitre, and a raised
erythrocyte sedimentation rate (mean 111 mm in the
first hour, range 58-150); the uptake of radioactive
iodine by the thyroid gland was subnormal in all five
and none had thyroid antibodies.
Erythrocyte zinc concentrations were measured by
atomic absorption spectrophotometry. ' The coefficient
of variation between days was 5%.
Erythrocyte zinc concentrations in the five patients
were compared with those in 30 patients with estab-
lished thyrotoxicosis and 110 control patients who
were euthyroid (figure). The mean erythrocyte zinc
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thyrotoxzcosis (A) and five patients with subacute thyroiditis (0).
Hatched area shows 2 SDs of mean in 110 euthyroid control patients
concentration in the patients with thyrotoxicosis
(105 (SD 64) [LmolI red cells) was significantly lower
than that in the euthyroid control patients (196
(50) jtmoVlI red cells, p<0O001). The mean erythrocyte
zinc concentration in the patients with subacute
thyroiditis was, however, 255 _mol!I red cells (range
185 6-394-7) and not significantly different from that
in the control group. One patient had an erythrocyte
zinc concentration of 394-7 [tmol/I red cells but he also
had a thalassaemia trait with microcytosis.
Comment
The normal erythrocyte zinc concentrations in our
patients show that their hyperthyroidism was transient
and therefore provides additional evidence to support
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